Koa Shoji Holdings Co.,Ltd. logo

Koa Shoji Holdings Co.,Ltd.

9273.T

JPXHealthcareDrug Manufacturers - Specialty & Generic

Latest quote

¥771

+¥4.00 · +0.52%

Aug 24, 3:30 PM JST

9273.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Koa Shoji Holdings Co.,Ltd., established in 1991 and headquartered in Yokohama, Japan, operates through its subsidiaries, engaging in a diverse array of pharmaceutical activities. The company sources and distributes active pharmaceutical ingredients and their precursors throughout the Japanese market. Additionally, it is involved in the production and commercialization of a range of injectable medications, alongside over-the-counter drugs, with a particular emphasis on vitamin formulations. Koa Shoji Holdings also manufactures and distributes generic pharmaceuticals. Complementing these operations, the firm provides outsourced drug production services and offers specialized packaging solutions for medicinal products.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
JP
CEO
Toshiyuki Shuto
Listed since
Jun 21, 2018
Employees
304

Market position

Volume
36.9K
0.46× average
Average volume
80.4K
Average daily volume
Market cap
32.47B JPY
Beta
0.52
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
18.04B JPY
EV / EBITDA
2.96×
Earnings yield
11.74%
Free cash flow yield
12.26%

Profitability & efficiency

Return on equity
12.02%
Return on assets
9.48%
Return on invested capital
10.64%

Financial health

Current ratio
3.64×
Altman Z-score
4.98
Piotroski F-score
3 of 9

Earnings

Latest EPS result
16.53

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates30.9825.6320.2714.92Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 11, 2024: actual 18.88, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 29.79, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 12, 2025: actual 21.61, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 16.11, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 7, 2025: actual 21.18, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 9, 2026: actual 28.35, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 11, 2026: actual 22.94, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 16.53, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates7.52B6.59B5.67B4.74BQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 11, 2024: actual 5.03B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 7.23B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 12, 2025: actual 5.36B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 5.65B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 7, 2025: actual 5.95B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 9, 2026: actual 6.7B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 11, 2026: actual 5.68B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 6.34B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock split

Effective Apr 28, 2021

2:1

Stock split

Effective Nov 4, 2020

2:1

Stock split

Effective Nov 1, 2018

3:1

9273.T peers

Continue in GoAI

Research 9273.T

research.disclaimer